RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Gary Gaufo to Receptors, Vasoactive Intestinal Peptide

This is a "connection" page, showing publications Gary Gaufo has written about Receptors, Vasoactive Intestinal Peptide.
  1. Xia M, Sreedharan SP, Bolin DR, Gaufo GO, Goetzl EJ. Novel cyclic peptide agonist of high potency and selectivity for the type II vasoactive intestinal peptide receptor. J Pharmacol Exp Ther. 1997 May; 281(2):629-33.
    View in: PubMed
    Score: 0.039
  2. Xia M, Gaufo GO, Wang Q, Sreedharan SP, Goetzl EJ. Transduction of specific inhibition of HuT 78 human T cell chemotaxis by type I vasoactive intestinal peptide receptors. J Immunol. 1996 Aug 01; 157(3):1132-8.
    View in: PubMed
    Score: 0.037
  3. Goetzl EJ, Pankhaniya RR, Gaufo GO, Mu Y, Xia M, Sreedharan SP. Selectivity of effects of vasoactive intestinal peptide on macrophages and lymphocytes in compartmental immune responses. Ann N Y Acad Sci. 1998 May 01; 840:540-50.
    View in: PubMed
    Score: 0.010
  4. Pankhaniya R, Jabrane-Ferrat N, Gaufo GO, Sreedharan SP, Dazin P, Kaye J, Goetzl EJ. Vasoactive intestinal peptide enhancement of antigen-induced differentiation of a cultured line of mouse thymocytes. FASEB J. 1998 Jan; 12(1):119-27.
    View in: PubMed
    Score: 0.010
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support